NOVEL PROTEINS AND NUCLEIC ACIDS ENCODING SAME

Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypep...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BAUMGARTNER, JASON, C, BURGESS, CATHERINE, E, SHIMKETS, RICHARD, A, SPYTEK, KIMBERLY, A, VERNET, CORINE, A., M, WOLENC, ADAM, R, GILBERT, JENNIFER, A, CASMAN, STACIE, J, DICKINSON, KEVIN, S, MISHRA, VISHNU, MAYOTTE, JANE, E, PADIGARU, MURALIDHARA, BALLINGER, ROBERT, A
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these human nucleic acids and proteins. L'invention concerne des séquences d'acides nucléiques qui codent de nouvelles peptides. L'invention concerne également des polypeptides codés par ces séquences d'acides nucléiques, des anticorps qui se lient de manière immunospéficique au polypeptide, ainsi que des dérivés, des variants, des mutants, ou des fragments des polypeptide, polynucléotide, ou anticorps précités. Par ailleurs, l'invention concerne des méthodes thérapeutiques, diagnostiques et de recherche servant à diagnostiquer, traiter ou prévenir des troubles impliquant l'un de ces nouveaux acides nucléiques et protéines humains.